Speakers 2024

Keynote Speech: Clinical Trials in Phage Therapeutics: Looking Under the Hood

Robert T. Schooley

University of California, San Diego, USA

Introduction to Targeting Phage Therapy 2024

Marvin Edeas

INSERM – Institut Cochin, Université de Paris, France

Adaptive Phage Therapy in The Intensive Care Unit: From Science to Patients

Ekaterina Chernevskaya

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Russia

Magistral Phage Preparations: Is This the Model for Everyone?

Jean-Paul Pirnay

Queen Astrid Military Hospital, Belgium

Mycobacteriophages and Their Therapeutic Potential

Graham F. Hatfull

University of Pittsburgh, USA
Barbara Brenner

Regulatory restrictions vs. Human Rights, the Hippocratic oath and the Freedom of therapy– The legal aspect of phage therapy

Barbara Brenner

Kanzlei BRENNER, Germany

Phage Therapy: A Glimpse into Clinical Studies Involving Over 150 Cases

Nannan Wu

Shanghai Public Health Clinical Center, Fudan University, China

Leveraging Evolutionary Trade-Offs in Development of Phage Therapy

Paul Turner

Yale University, USA

Genetic Engineering of Phages to Target Intracellular Bloodstream E.coli Infections

Antonia P. Sagona

University of Warwick, United Kingdom

Quality control of phage Active Pharmaceutical Ingredients (APIs) in Belgium

Pieter-Jan Ceyssens

Sciensano, Belgium

The Phageome in Normal and Inflamed Human Skin

Wolfgang Weninger

Medical University of Vienna, Austria

Making Antibiotics Great Again: Phage resistance in vivo correlates to resensitivity to antibiotics in pan-resistant Pseudomonas aeruginosa

Sabrina Green

KU Leuven, Belgium

Modern Concepts of Phage Therapy: An Immunologist’s Vision

Besarion Lasareishvili

Eliava Institute of Bacteriophage, Microbiology and Virology, Georgia

Improving Phages Through Experimental Evolution

Frederic Bertels

Max Planck Institute for Evolutionary Biology, Germany

Addressing Phage Resistance to Enhance the Robustness of Phage Therapy for Pseudomonas aeruginosa Infections in People with Cystic Fibrosis

Federica Briani

University of Milan, Italy

Phage Satellites, a Diversity of Extradimensional Symbionts and Pathways to Phage Therapy 

Rodrigo Ibarra Chávez

University of Copenhagen, Denmark

Towards efficient phage therapies: investigation of phage / bacteria equilibrium with metagenome of dark matter in natural samples

Domenico Frezza

University of Roma Tor Vergata, Italy

Cell-Free Production of Personalized Therapeutic Phages Targeting Multidrug-Resistant Bacteria

Kilian Vogele

Invitris, Germany

Phage therapy: Targeting intestinal bacterial microbiota for the treatment of Liver disease

Jumpei Fujiki

University of California San Diego, USA